Study Progress of Coronary Artery Damage in Kawasaki Disease

References (42)

1. 1 The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin [DOI]
2. 2 Mitochondrial DNA in innate immune responses and inflammatory pathology [DOI]
3. 3 HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE [DOI]
4. 4 Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial [DOI]
5. 5 Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice [DOI]
6. 6 Pleiotropic effects of oxidized phospholipids [DOI]
7. 7 Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells [DOI]
8. 8 Kawasaki Disease: Pathology, Risks, and Management [DOI]
9. 9 Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?—Current evidence based on a meta-analysis [DOI]
10. 10 Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight [DOI]
11. 11 Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency [DOI]
12. 12 Kawasaki Disease as a Systemic Vasculitis in Childhood [DOI]
13. 13 Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness [DOI]
14. 14 Enhanced iNOS Expression in Leukocytes and Circulating Endothelial Cells Is Associated with the Progression of Coronary Artery Lesions in Acute Kawasaki Disease [DOI]
15. 15 Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease [DOI]
16. 16 [The expert consensus on diagnosis and acute-phase treatment of Kawasaki disease]. [DOI]
17. 17 Utilizing single-cell RNA sequencing for analyzing the characteristics of PBMC in patients with Kawasaki disease [DOI]
18. 18 Overexpressed Neuropilin‐1 in Endothelial Cells Promotes Endothelial Permeability through Interaction with ANGPTL4 and VEGF in Kawasaki Disease [DOI]
19. 19 CD36 is Associated With the Development of Coronary Artery Lesions in Patients With Kawasaki Disease [DOI]
20. 20 The role of FOXO4/NFAT2 signaling pathway in dysfunction of human coronary endothelial cells and inflammatory infiltration of vasculitis in Kawasaki disease [DOI]
21. 21 Kawasaki disease in Sicily: clinical description and markers of disease severity [DOI]
22. 22 Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease [DOI]
23. 23 Cell Distribution Differences Of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients With Kawasaki Disease [DOI]
24. 24 A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better? [DOI]
25. 25 Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease [DOI]
26. 26 Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease. [DOI]
27. 27 Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease [DOI]
28. 28 Significantly Lower Immunoglobulin M Levels 6 Months After Disease Onset in Patients With Kawasaki Disease With Coronary Artery Lesions [DOI]
29. 29 The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease [DOI]
30. 30 Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions [DOI]
31. 31 AST-to-ALT ratio and coronary artery lesions among patients with Kawasaki disease [DOI]
32. 32 Risk Factors for Coronary Artery Lesionsin Kawasaki Disease Independent of Antibiotic Use in Chinese Children [DOI]
33. 33 [Interpretation of the JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease]. [DOI]
34. 34 Integrative treatment of herbal medicine with western medicine on coronary artery lesions in children with Kawasaki disease [DOI]
35. 35 Breastfeeding has no protective effects on the development of coronary artery lesions in Kawasaki disease: a retrospective cohort study [DOI]
36. 36 Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease [DOI]
37. 37 Water retention in the acute phase of Kawasaki disease: relationship between oedema and the development of coronary arterial lesions [DOI]
38. 38 Integrin α2 gene polymorphism is a risk factor of coronary artery lesions in Chinese children with Kawasaki disease [DOI]
39. 39 Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease [DOI]
40. 40 High Serum Total IgE at Admission Is Associated with Coronary Artery Lesions in Children with Kawasaki Disease [DOI]
41. 41 Cyclosporine and coronary outcomes in Kawasaki disease [DOI]
42. 42 Predictive value of brachial artery flow-mediated dilation on coronary artery abnormality in acute stage of Kawasaki disease [DOI]

Cited by 0

No indexed citations yet.

Related research

• Oesophageal Foreign Bodies Impaction in Nigerian Adults: A Preventable Consequence — shares topic coverage
• Epidemiological Analysis of Infective Endocarditis at the Gold Coast Area Health Service, Australia — shares topic coverage
• Reproductive Factors Associated with the Risk of Breast Cancer among Malaysian Women: A Multi-Centre Case-Control Study — shares topic coverage
• Analysis of Risk Factors among Diabetic Patients Visiting Diabetic Research Clinic at Nishtar Hospital Multan-Pakistan — shares topic coverage
• Seroprevalence of Helicobacter pylori Ig G Antibody and Risk Factors in Hypertensive Patients at Dschang District Hospital in Cameroon — shares topic coverage